Skip to main content
. Author manuscript; available in PMC: 2018 Mar 30.
Published in final edited form as: Ann Intern Med. 2017 Aug 22;167(6):384–393. doi: 10.7326/M17-0520

TABLE 1.

BASELINE CHARACTERISTICS OF THE STUDY PARTICIPANTS

MVC MVC+FTC MVC+TDF TDF+FTC TOTAL
Enrolled (N) 46 45 49 48 188
Sex (% born female) 100% 100% 100% 100% 100%
Age, median (years) 40 36 37 37 35
Age, min, max (years) 18, 61 19, 57 22, 60 18, 60 18, 61
Race (%)*
American Indian/Alaskan Native 0% 4% 2% 4% 3%
Asian 2% 0% 2% 0% 1%
Black 65% 69% 65% 62% 65%
Pacific Islander 0% 0% 0% 2% 1%
White 26% 29% 29% 25% 27%
Other 9% 9% 4% 10% 8%
Ethnicity – Latina (%) 20% 13% 16% 19% 17%
Marital status (%)
Married/partnership 6% 11% 8% 21% 12%
Living with primary partner 26% 20% 18% 10% 19%
Not living with primary partner 13% 4% 10% 15% 11%
Single/divorced/widowed 54% 62% 61% 54% 58%
Other 0% 2% 2% 0% 1%
Employment status (%)
Full-time 20% 33% 22% 19% 23%
Part-time 37% 22% 16% 15% 22%
Unemployed 43% 44% 61% 67% 54%
Education (%)
Less than high school 15% 11% 8% 15% 12%
High school/trade school 35% 40% 37% 37% 37%
Some college 33% 29% 31% 35% 32%
Finished college 13% 13% 22% 10% 15%
Advanced degree 4% 7% 2% 2% 4%

MVC, maraviroc, FTC, emtricitabine, TDF, tenofovir disoproxil fumarate.

*

Participants could self-identify as more than one race.